Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Issue of Equity

5 Nov 2012 17:01

RNS Number : 3752Q
Maven Income and Growth VCT 3 PLC
05 November 2012
 



MAVEN INCOME AND GROWTH VCT 3 PLC

Enhanced Buyback Scheme

The board of directors ("Board") of Maven Income and Growth VCT 3 PLC ("the Company") is pleased to announce that the Company's enhanced buyback scheme in respect of the ordinary shares of 10p each in the capital of the Company ("Enhanced Buyback Scheme") has now closed.

Due to a successful uptake under the Enhanced Buyback Scheme, the number of ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") tendered under the Enhanced Buyback Scheme exceeded the number of Ordinary Shares available for purchase by the Company, all correctly completed applications have been scaled back and accepted as follows in accordance with the terms of the Enhanced Buyback Scheme:

Firstly, valid applications from all shareholders eligible to participate have been accepted to the extent that the number of existing Ordinary Shares to be purchased represented 14.99% or less of their holding of Ordinary Shares on 21 September 2012 (rounded down to the nearest whole number of Ordinary Shares) and secondly, valid applications thereafter have been accepted pro rata to the number of Ordinary Shares tendered.

The date for purchasing existing Ordinary Shares and for issuing new Ordinary Shares pursuant to the Enhanced Buyback Scheme was extended to 5 November 2012 from the expected date of 31 October 2012 to allow for additional administrative formalities to be completed. The Company has, therefore, today purchased 4,708,436 Ordinary Shares at a price of 82.60 pence per share and allotted 4,566,741 Ordinary Shares at 85.16 pence per share pursuant to the Enhanced Buyback Scheme.

The new Ordinary Shares rank pari passu in all respects with the existing share capital of the Company.

Application has been made to the UK Listing Authority and the London Stock Exchange for the new Ordinary Shares to be admitted to the Official List and to trade on the London Stock Exchange's main market for listed securities. It is expected that admission will become effective and dealings will commence on, or around, 9 November 2012.

As a result, of the buyback and allotment of shares undertaken today pursuant to the Enhanced Buyback Scheme, there are now 31,219,892 Ordinary Shares in issue.

The above figures may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.

For further enquiries, please contact:

 

Maven Capital Partners UK LLP, Secretary

0141 306 7400

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOELLFIDLLLEIIF
Date   Source Headline
20th May 202610:00 amRNSAdmission of Further Securities to Trading
15th May 202610:05 amRNSIssue of Equity - Dividend Investment Scheme
12th May 20263:35 pmRNSUnaudited NAV - Dividend Investment Scheme
8th May 20267:00 amRNSTransaction in Own Shares
30th Apr 20261:30 pmRNSResult of AGM
30th Apr 202610:54 amRNSAdmission of Further Securities to Trading
29th Apr 202612:28 pmRNSIssue of Equity
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:19 amRNSAdmission of Further Securities to Trading
14th Apr 202611:07 amRNSIssue of Equity
8th Apr 20269:28 amRNSAdmission of Further Securities to Trading
25th Mar 202610:54 amRNSAdmission of Further Securities to Trading
24th Mar 20265:32 pmRNSAnnual Financial Report
24th Mar 202612:11 pmRNSIssue of Equity
17th Mar 20264:36 pmRNSNet Asset Value(s)
27th Feb 20265:01 pmRNSTransaction in Own Shares
27th Feb 20267:00 amRNSUnaudited NAV and Dividend Declaration
18th Feb 20264:52 pmRNSAdmission of Further Securities to Trading
17th Feb 202611:05 amRNSDirector/PDMR Shareholding
17th Feb 202611:02 amRNSDirector/PDMR Shareholding
17th Feb 202611:02 amRNSDirector/PDMR Shareholding
17th Feb 202611:00 amRNSDirector/PDMR Shareholding
17th Feb 202610:55 amRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
21st Jan 202611:03 amRNSAdmission of Further Securities to Trading
16th Jan 20269:42 amRNSIssue of Equity
14th Jan 20262:35 pmRNSUnaudited NAV - Dividend Investment Scheme
16th Dec 202510:20 amRNSIssue of Equity
4th Dec 202510:35 amRNSUnaudited NAV and Second Interim Dividend
13th Nov 20254:47 pmRNSResult of General Meeting
28th Oct 20254:24 pmRNSTransaction in Own Shares
2nd Oct 20254:42 pmRNSPublication of a Prospectus
15th Sep 20251:08 pmRNSNet Asset Value(s)
29th Aug 20257:00 amRNSIssue of Equity
20th Aug 20252:13 pmRNSStatement re Dividend Investment Scheme
23rd Jul 20254:30 pmRNSHalf-year Report
22nd Jul 20254:49 pmRNSTransaction in Own Shares
16th Jul 20257:08 amRNSStatement re Offer for Subscription
10th Jul 20254:46 pmRNSStatement re Unaudited NAV and Interim Dividend
15th May 20253:57 pmRNSTransaction in Own Shares
9th May 20259:54 amRNSDirector/PDMR Shareholding
9th May 20259:51 amRNSIssue of Equity
6th May 202511:53 amRNSIssue of Equity
2nd May 20251:11 pmRNSAudited NAV - Dividend Investment Scheme
1st May 20253:15 pmRNSResult of AGM
17th Apr 202512:56 pmRNSPublication of Suppl.Prospcts
7th Apr 20257:00 amRNSIssue of Equity - Replacement
4th Apr 20256:17 pmRNSIssue of Equity
1st Apr 202512:59 pmRNSStatement re Offers for Subscription - Closed
27th Mar 20251:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.